XI'AN,
China, Sept. 30, 2022 /PRNewswire/ -- Bon Natural
Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the
leading bio-ingredient solutions providers in the natural, health
and personal care industries, today announced that there will be a
delay to the initial production target of Q4 2022 for its third
production site – Yumen Plant to
May 2023.
BON has completed the building structure of the facility in
May 2022 as scheduled and expected to
commence around September this year. However, against the backdrop
of the strict COVID-19 control protocol and prevention policies in
China, the lingering logistic
disruption, material and labor shortage, and domestic travel
restriction have caused delay in Yumen
Plant's interior outfitting, site inspection, and equipment
installation.
"Since we broke ground in July
2021, we at BON have worked tirelessly to advance our
production expansion project." Commented Richard Hu, CEO and
Chairman of BON, "We expect that Yumen Factory will commence around
May 2023 to deliver near term
production of fragrance compounds and bioactive food ingredients.
In addition to above external factors beyond our control, possible
tighter COVID-19 control protocol in winter time and the lunar New
Year holiday in January are factored in the estimate of obtaining
the required regulatory approval of our third production plant. We
are currently working closely with local authorities to accelerate
the construction progress, and we believe that Yumen Plant will mark a significant milestone in
our growth in due course during this challenging environment."
About Bon Natural Life Limited
The Company focuses on the manufacturing of personal care
ingredients, such as plant extracted fragrance compounds for
perfume and fragrance manufacturers, natural health supplements
such as powder drinks and bioactive food ingredient products mostly
used as food additives and nutritional supplements by their
customers. For additional information, please visit the Company's
website at www.bnlus.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may, "will, "intend," "should," "believe," "expect," "anticipate,"
"project," "estimate" or similar expressions that do not relate
solely to historical matters, it is making forward-looking
statements. Forward-looking statements are not guarantees of future
performance and involve risks and uncertainties that may cause the
actual results to differ materially from the Company's expectations
discussed in the forward-looking statements. These statements are
subject to uncertainties and risks including, but not limited to,
the following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the natural, health and personal care market in China and the other international markets the
Company plans to serve; reputation and brand; the impact of
competition and pricing; government regulations; fluctuations in
general economic and business conditions in China and the international markets the
Company plans to serve and assumptions underlying or related to any
of the foregoing and other risks contained in reports filed by the
Company with the SEC. For these reasons, among others, investors
are cautioned not to place undue reliance upon any forward-looking
statements in this press release. Additional factors are discussed
in the Company's filings with the SEC, which are available for
review at www.sec.gov. The Company undertakes no obligation to
publicly revise these forward–looking statements to reflect events
or circumstances that arise after the date hereof.
For more information, please
contact:
Maggie Zhang | Impact
IR
|
Sophie Zhang | Impact IR
|
Phone: (646)
893-8916
|
Phone: (917)
830-5219
|
Email: maggie.zhang@irimpact.com
|
Email: sophie.zhang@irimpact.com
|
View original
content:https://www.prnewswire.com/news-releases/bon-natural-life-limited-provides-update-on-its-expansion-project-301638112.html
SOURCE Bon Natural Life Limited